SM
Summit Therapeutics
SMMT · NASDAQ
$16.90 -3.68% (-$0.65)
1M +32.76%
Market Cap $13.5B
P/E Ratio -
Div. Yield -
ROE 204.33%
Bulios Fair Price
$12.49
26.1% downside
Trenutna cena
$16.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SMMT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 21.40x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 67.93%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 134.14%
ROE 204.33%
ROA 113.81%
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 6.96x
Int. coverage N/A
Stability
19 /100
Unstable Beta -1.24x
EPS volatility 275.36%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SMMT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert W. Duggan
Employees
265
Headquarters
Miami
Prihajajoči dogodki
19 OKT.
Earnings
Upcoming earnings report